Whistler Medical Marijuana: Aurora Cannabis Wraps 'Accretive' Whistler Medical Acquisition

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) announced the completion Monday of its all-share acquisition of the privately held Whistler Medical Marijuana Corporation, an organic cannabis company and one of Canada's first 10 licensed producers. Aurora's acquisition comes via a sale with Cronos Group Inc. (NASDAQ: CRON) for approximately 19 percent of Whistler's issued and outstanding common shares. The agreement is for approximately CA$175 million ($131.3 million). Why It's ImportantUnder the terms of the agreement, Aurora obtains all the issued and outstanding shares of Whistler. The acquisition adds additional high-quality products ...Full story available on Benzinga.com